Zaineb A.F. Albayati
Role not yet determined Is this you? Add your title
Also affiliated: University of Kentucky (2007–2008)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Zaineb A.F. Albayati's research has focused on the pharmacological effects and toxicity of various compounds, particularly in preclinical models. Her work includes an investigation into the bone and kidney toxicity of BT2-peg2, a compound explored for targeted antibiotic delivery. Additionally, she has conducted pharmacokinetic studies of morphine-6-O-sulfate, examining its distribution in rat plasma and brain tissue. Albayati has a publication record of nine papers, with 59 citations and an h-index of 5. Her collaborations include shared publications with researchers at the University of Arkansas for Medical Sciences, such as Narsimha Reddy Penthala and Peter A. Crooks.
Metrics
- h-index: 5
- Publications: 11
- Citations: 135
Selected Publications
-
Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone (2021)
-
A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain (2021)
-
Stability studies of potent opioid analgesic, morphine‐6‐O‐sulfate in various buffers and biological matrices by HPLC‐DAD analysis (2017)
-
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia (2016)
-
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone (2015)
-
In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche (2015)
-
(434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain (2015)
Collaboration Network
Top Collaborators
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone
- Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia
- Stability studies of potent opioid analgesic, morphine‐6‐O‐sulfate in various buffers and biological matrices by HPLC‐DAD analysis
- Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone
Showing 5 of 7 shared publications
- Stability studies of potent opioid analgesic, morphine‐6‐O‐sulfate in various buffers and biological matrices by HPLC‐DAD analysis
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain
- Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain
- Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone
- Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia
- A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain
- Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone
- Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone
- Stability studies of potent opioid analgesic, morphine‐6‐O‐sulfate in various buffers and biological matrices by HPLC‐DAD analysis
- A pharmacokinetic study of morphine‐6‐O ‐sulfate in rat plasma and brain
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- (434) Analgesic profile of morphine 6-O-sulfate sodium: a mixed mu/delta agonist in the treatment of diabetic neuropathic pain
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
- In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche
Similar Researchers
Based on overlapping research topics